Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy (HPDSC+HIE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02434965 |
|
Recruitment Status :
Withdrawn
(Study not started)
First Posted : May 6, 2015
Last Update Posted : February 23, 2021
|
Sponsor:
New York Medical College
Collaborator:
Celgene
Information provided by (Responsible Party):
New York Medical College
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | January 2021 |
| Estimated Study Completion Date : | January 2022 |